AU2010284116B9 - Purification of VWF for increased removal of non-lipid enveloped viruses - Google Patents
Purification of VWF for increased removal of non-lipid enveloped viruses Download PDFInfo
- Publication number
- AU2010284116B9 AU2010284116B9 AU2010284116A AU2010284116A AU2010284116B9 AU 2010284116 B9 AU2010284116 B9 AU 2010284116B9 AU 2010284116 A AU2010284116 A AU 2010284116A AU 2010284116 A AU2010284116 A AU 2010284116A AU 2010284116 B9 AU2010284116 B9 AU 2010284116B9
- Authority
- AU
- Australia
- Prior art keywords
- protein
- containing solution
- cation exchange
- exchange resin
- vwf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015201483A AU2015201483A1 (en) | 2009-08-20 | 2015-03-20 | Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23557009P | 2009-08-20 | 2009-08-20 | |
| US61/235,570 | 2009-08-20 | ||
| PCT/US2010/046180 WO2011022657A1 (en) | 2009-08-20 | 2010-08-20 | Purification of vwf for increased removal of non-lipid enveloped viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015201483A Division AU2015201483A1 (en) | 2009-08-20 | 2015-03-20 | Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2010284116A1 AU2010284116A1 (en) | 2012-03-08 |
| AU2010284116B2 AU2010284116B2 (en) | 2015-02-12 |
| AU2010284116B9 true AU2010284116B9 (en) | 2015-03-26 |
Family
ID=43063204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010284116A Active AU2010284116B9 (en) | 2009-08-20 | 2010-08-20 | Purification of VWF for increased removal of non-lipid enveloped viruses |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9315560B2 (enExample) |
| EP (1) | EP2467399B2 (enExample) |
| JP (1) | JP5838159B2 (enExample) |
| KR (1) | KR101894600B1 (enExample) |
| CN (2) | CN106008697B (enExample) |
| AU (1) | AU2010284116B9 (enExample) |
| BR (1) | BR112012003802B1 (enExample) |
| CA (1) | CA2771232A1 (enExample) |
| DK (1) | DK2467399T3 (enExample) |
| ES (1) | ES2562256T5 (enExample) |
| HU (1) | HUE026907T2 (enExample) |
| IN (1) | IN2012DN01849A (enExample) |
| MX (1) | MX2012002129A (enExample) |
| NZ (1) | NZ598249A (enExample) |
| PL (1) | PL2467399T3 (enExample) |
| PT (1) | PT2467399E (enExample) |
| SG (2) | SG10201408106WA (enExample) |
| WO (1) | WO2011022657A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
| KR101772674B1 (ko) | 2008-10-21 | 2017-09-01 | 박스알타 인코퍼레이티드 | 동결건조된 재조합 ｖｗｆ 제제 |
| SG11201408490PA (en) * | 2012-06-21 | 2015-01-29 | Baxter Int | Virus filtration of cell culture media |
| US9902942B2 (en) | 2013-02-22 | 2018-02-27 | Agency For Science, Technology And Research | Chromatographic purification of virus preparations with negatively charged particles |
| DK3152230T3 (da) * | 2014-06-06 | 2019-11-11 | Octapharma Ag | Præparat omfattende faktor viii og von willebrand-faktor-peptider |
| DK3158055T3 (da) | 2014-06-13 | 2019-10-14 | Csl Ltd | Forbedret produktion af recombinant von willebrand-faktor i en bioreaktor |
| KR20250088663A (ko) | 2017-08-23 | 2025-06-17 | 체에스엘 베링 게엠베하 | 폰 빌레브란트 인자의 바이러스 여과 방법 |
| EP3768697A1 (en) | 2018-03-21 | 2021-01-27 | Baxalta Incorporated | Separation of vwf and vwf propeptide by chromatographic methods |
| CA3244889A1 (en) | 2022-03-08 | 2023-09-14 | Equashield Medical Ltd | FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941763A (en) * | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
| EP0218692A4 (en) | 1985-04-11 | 1988-03-22 | Childrens Medical Center | VON WILLEBRAND FACTOR. |
| US5728553A (en) * | 1992-09-23 | 1998-03-17 | Delta Biotechnology Limited | High purity albumin and method of producing |
| AT406373B (de) * | 1997-02-27 | 2000-04-25 | Immuno Ag | Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie |
| AT405403B (de) * | 1997-02-27 | 1999-08-25 | Immuno Ag | Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie |
| AT405485B (de) | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
| US6531577B1 (en) † | 1997-12-15 | 2003-03-11 | Hemasure Denmark A/S | von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations |
| ES2261589T3 (es) * | 1998-05-06 | 2006-11-16 | Genentech, Inc. | Composicion de anticuerpos anti-her2. |
| AU2005322067B8 (en) * | 2004-12-27 | 2012-07-26 | Takeda Pharmaceutical Company Limited | Polymer-von Willebrand factor-conjugates |
-
2010
- 2010-08-20 IN IN1849DEN2012 patent/IN2012DN01849A/en unknown
- 2010-08-20 JP JP2012525731A patent/JP5838159B2/ja active Active
- 2010-08-20 EP EP10747134.4A patent/EP2467399B2/en active Active
- 2010-08-20 CN CN201610190778.2A patent/CN106008697B/zh active Active
- 2010-08-20 CA CA2771232A patent/CA2771232A1/en active Pending
- 2010-08-20 HU HUE10747134A patent/HUE026907T2/en unknown
- 2010-08-20 PT PT107471344T patent/PT2467399E/pt unknown
- 2010-08-20 WO PCT/US2010/046180 patent/WO2011022657A1/en not_active Ceased
- 2010-08-20 MX MX2012002129A patent/MX2012002129A/es active IP Right Grant
- 2010-08-20 DK DK10747134.4T patent/DK2467399T3/en active
- 2010-08-20 KR KR1020127005935A patent/KR101894600B1/ko active Active
- 2010-08-20 PL PL10747134T patent/PL2467399T3/pl unknown
- 2010-08-20 ES ES10747134T patent/ES2562256T5/es active Active
- 2010-08-20 AU AU2010284116A patent/AU2010284116B9/en active Active
- 2010-08-20 SG SG10201408106WA patent/SG10201408106WA/en unknown
- 2010-08-20 SG SG2012011177A patent/SG178478A1/en unknown
- 2010-08-20 BR BR112012003802-8A patent/BR112012003802B1/pt active IP Right Grant
- 2010-08-20 NZ NZ598249A patent/NZ598249A/en unknown
- 2010-08-20 CN CN2010800395824A patent/CN102482341A/zh active Pending
- 2010-08-20 US US12/860,501 patent/US9315560B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK2467399T3 (en) | 2017-01-23 |
| US20110092681A1 (en) | 2011-04-21 |
| CN106008697A (zh) | 2016-10-12 |
| BR112012003802A2 (pt) | 2016-11-22 |
| CN106008697B (zh) | 2020-08-04 |
| ES2562256T3 (es) | 2016-03-03 |
| AU2010284116B2 (en) | 2015-02-12 |
| BR112012003802B1 (pt) | 2022-10-25 |
| EP2467399B1 (en) | 2015-11-11 |
| NZ598249A (en) | 2014-04-30 |
| IN2012DN01849A (enExample) | 2015-08-21 |
| EP2467399B2 (en) | 2023-02-01 |
| SG178478A1 (en) | 2012-04-27 |
| CA2771232A1 (en) | 2011-02-24 |
| PL2467399T3 (pl) | 2016-05-31 |
| JP2013502434A (ja) | 2013-01-24 |
| US9315560B2 (en) | 2016-04-19 |
| KR101894600B1 (ko) | 2018-09-03 |
| ES2562256T5 (es) | 2023-07-20 |
| HUE026907T2 (en) | 2016-07-28 |
| WO2011022657A1 (en) | 2011-02-24 |
| MX2012002129A (es) | 2012-06-08 |
| PT2467399E (pt) | 2016-03-18 |
| CN102482341A (zh) | 2012-05-30 |
| EP2467399A1 (en) | 2012-06-27 |
| JP5838159B2 (ja) | 2015-12-24 |
| AU2010284116A1 (en) | 2012-03-08 |
| KR20120065342A (ko) | 2012-06-20 |
| SG10201408106WA (en) | 2015-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010284116B9 (en) | Purification of VWF for increased removal of non-lipid enveloped viruses | |
| KR101700722B1 (ko) | 응고 인자 ｖｉｉｉ을 정제하는 방법 | |
| RU2579977C2 (ru) | СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ | |
| JP7458980B2 (ja) | アルキルグリコシドによるタンパク質精製およびウイルス不活化 | |
| KR20040111351A (ko) | 단백질 제제의 안정화 | |
| EP2125866A1 (en) | Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules | |
| VOSS et al. | Expression of human interferon ω1 in Sf9 cells: No evidence for complex‐type N‐linked glycosylation or sialylation | |
| KR20170083166A (ko) | 형질전환 인자 ⅶ 의 정제 방법 | |
| US6034222A (en) | Method for the separation of recombinant pro-factor IX from recombinant factor IX | |
| US8058411B2 (en) | Method for producing mature VWF from VWF pro-peptide | |
| AU2015201483A1 (en) | Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses | |
| CN112533940A (zh) | 通过色谱方法分离vwf和vwf前肽 | |
| KR20210141608A (ko) | 치료요법에서 인자 ix 변이체 및 이의 용도 | |
| HK1230206A1 (en) | Purification of vwf for increased removal of non-lipid enveloped viruses | |
| HK1170744A (en) | Purification of vwf for increased removal of non-lipid enveloped viruses | |
| HK1230206B (zh) | 纯化vwf以增加非-脂质包封的病毒的去除 | |
| HK40050722A (en) | Separation of vwf and vwf propeptide by chromatographic methods | |
| Sima et al. | Construction and Expression of a New Modified Coagulation FVIII cDNA In NIH3T3, CHO, and HepG2 Cell Lines | |
| HK1144577B (en) | Method for producing mature vwf from vwf pro-peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished | ||
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: BAXALTA GMBH; BAXALTA INCORPORATED Free format text: FORMER OWNER WAS: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A. |
|
| PC | Assignment registered |
Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED Free format text: FORMER OWNER(S): BAXALTA INCORPORATED; BAXALTA GMBH |